Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic biomarkers for prediction of recurrence of hepatocellular carcinoma: current status and future prospects.

World journal of gastroenterology - 28 Mar 2014

Lee Seow Chong, Tan Hwee Tong, Chung Maxey Ching Ming

Abstract excerpt

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death worldwide, with region specific etiologies. Despite improvements made in the diagnosis of HCC, the prognosis of HCC patients remains poor due to the high recurrence rate of HCC. There is an urgent need for development of prognostic biomarkers to predict the risk of recurrence in HCC patients after "curative" treatment. Such stratification...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Hepatocellular
Share to Hepatitis B

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C

Share to Liver Neoplasms

Share to MicroRNAs

Share to Neoplasm Recurrence, Local

Share to Proteomics

Share to Transcriptome

Source

Open in PubMed Open full text

Identifiers

PMID: 24696598
DOI: 10.3748/wjg.v20.i12.3112
PMCID: PMC3964383

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic biomarkers for prediction of recurrence of hepatocellular carcinoma: current status and future prospects.PMID 24696598Read ↗

Integrative multi-omics approach for stratification of tumor recurrence risk groups of Hepatocellular Carcinoma patientsSemantic proximity Read ↗

Multiple “Omics” data-based biomarker screening for hepatocellular carcinoma diagnosisSemantic proximity Read ↗

Identification of serum metabolite biomarkers and metabolic reprogramming mechanisms to predict recurrence in cholangiocarcinomaSemantic proximity Read ↗

Novel hepatocellular carcinomas (HCC) Subtype-Specific BiomarkersSemantic proximity Read ↗

Combined proteomic/transcriptomic signature of recurrence post-liver transplantation for hepatocellular carcinoma beyond MilanSemantic proximity Read ↗

An overview of hepatocellular carcinoma study by omics-based methodsSemantic proximity Read ↗

New biomarkers and therapeutic targets of human liver cancer: Transcriptomic findingsSemantic proximity Read ↗

Emerging evidence of molecular biomarkers in hepatocellular carcinoma.Semantic proximity Read ↗

Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma.Semantic proximity Read ↗

Proteomic Profiling and Biomarker Discovery in Colorectal Liver MetastasesSemantic proximity Read ↗

Genomic alterations in hepatocellular carcinoma patients undergoing liver transplantation predict recurrence and prognosisSemantic proximity Read ↗

Development and Validation of a Propionate Metabolism-Related Gene Signature for Prognostic Prediction of Hepatocellular CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.